{
    "SPADE_UN_27639": {
        "Sequence Information": {
            "Peptide Name": "Retrocyclin-112, RC-112",
            "Sequence": "GICRCICGRGICRCICGR",
            "Sequence Length": 18,
            "Biological Activity": [
                "Anti-Gram+",
                "Antiviral",
                "Anticancer"
            ],
            "Binding Target": "1. Membrane Protein\n2. Lipid Bilayer\n3. Virus entry\n4. gp120",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "A theta-defensin composed exclusively of D-amino acids is active against HIV-1.",
                    "Pubmed ID": "15175019",
                    "Reference": "J Pept Res. 2004;63:469-476",
                    "Author": "Owen SM, Rudolph D, Wang W, Cole AM, Sherman MA, Waring AJ, Lehrer RI, Lal RB",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15175019"
                },
                {
                    "Title": "Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.",
                    "Pubmed ID": "16790431",
                    "Reference": "J Biol Chem. 2006;281:32755-32764",
                    "Author": "Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, Lehrer RI",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16790431"
                }
            ],
            "Mass": 1942.45,
            "PI": 9.01,
            "Net Charge": 4,
            "Hydrophobicity": 0.74,
            "Frequent Amino Acids": "CGI",
            "Absent Amino Acids": "ADEFHKLMNOPQSTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 8,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_27639",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03436",
                    "Similarity": 1.0,
                    "Sequence": "RCICGRGICRCICGRGIC"
                },
                {
                    "SPADE_ID": "SPADE_UN_09523",
                    "Similarity": 1.0,
                    "Sequence": "RCICGRGIC"
                },
                {
                    "SPADE_ID": "SPADE_UN_27638",
                    "Similarity": 1.0,
                    "Sequence": "GICRCICGRGICRCICGR"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1B 92US076(IC50 I=1.02µg/ml),HIV-1B 93US151(IC50 I=0.53µg/ml),HIV-1B 92HT593(IC50 I=1.27µg/ml),HIV-1B 92US727(IC50 I=1.64µg/ml),HIV-1B 92US657(IC50 I=0.91µg/ml),HIV-1B 92US714(IC50 I=2.74µg/ml),HIV-1A 193317(IC50 I=5.94µg/ml),HIV-1A 196554(IC50 I=2.47µg/ml),HIV-1A 196531(IC50 I=1.93-2.01µg/ml),HIV-1A 92RW026(IC50 I=1.62µg/ml),HIV-1C 192431(IC50 I=2.21-2.79µg/ml),HIV-1C 97ZA003(IC50 I=1.22µg/ml),HIV-1C UG95-175(IC50 I=3.13µg/ml),HIV-1C 93MW959(IC50 I=1.70µg/ml),HIV-1D 93UG053(IC50 I=1.43µg/ml),HIV-1D 92UG005(IC50 I=2.03µg/ml),HIV-1D 94UG114(IC50 I=1.34µg/ml),HIV-1 CRF01-AE CMU08(IC50 I=1.15µg/ml),HIV-1 CRF01-AE CMU10(IC50 I=2.35µg/ml),HIV-1 CRF01-AE HM14(IC50 I=1.28µg/ml),HIV-1 CRF01-AE HM13(IC50 I=1.98µg/ml),HIV-1 CRF01-AE HM16(IC50 I=0.91µg/ml),HIV-1 CRF01-AE 92TH001(IC50 I=2.81µg/ml),HIV-1 CRF01-AE 93TH060(IC50 I=1.36µg/ml),HIV-1G RU132(IC50 I=1.22µg/ml),HIV-1G RU570(IC50 I=1.27µg/ml),Human adenocarcinoma TZM-bl(no activity data),Bacillus anthracis Sterne 7702(MEC=0.99±0.05µg/ml),Bacillus anthracis Sterne 7702(MEC=0.51±0.02µg/ml)"
        }
    }
}